Key Record Dates
ClinicalTrials.gov Identifier: | NCT03928743 |
---|---|
Brief Title: | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis (BE MOBILE 2) |
First Submitted : | April 23, 2019 |
First Submitted that Met QC Criteria : | April 23, 2019 |
First Posted : | April 26, 2019 |
Certification/Extension First Submitted : | September 1, 2022 |
Certification/Extension First Submitted that Met QC Criteria : | September 1, 2022 |
Certification/Extension First Posted : | September 2, 2022 |
Last Update Submitted that Met QC Criteria : | February 22, 2023 |
Last Update Posted : | February 27, 2023 |